The goal of this internet broadcast is to deliver focused, educational updates highlighting clinically relevant advances in the management of patients with IBS and IBS-like symptoms.
Upon completion of this activity, participants should be able to:
- Design evidence-based treatment plans for patients with IBS that are aligned with current evidence-based recommendations
- Understand the methodologic quality of study design, magnitude of benefit of specific IBS treatments, safety, and tolerability of these therapies
- Incorporate new IBS recommendations effectively into clinical practice
Release Date: 02/11/21
Expiration Date: 02/11/22
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and the Gi Health Foundation. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.
Purdue University College of Pharmacy designates this internet broadcast for a maximum of 1.5 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All faculty, staff and reviewers involved in the planning, review or presentation of continuing education activities provided by Purdue University College of Pharmacy are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.
All additional planning committee members, staff and reviewers of the GI Health Foundation and Purdue University College of Pharmacy have no relationships to disclose.
Supported by educational grants from Salix Pharmaceuticals and Gemelli Biotech